Yanwei Ding

Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes.

Jun Xu, H. Ge, P. Peng, 2014, ACS medicinal chemistry letters.

Developing a novel dual PI3K–mTOR inhibitor from the prodrug of a metabolite

Yan Zhou, S. You, Chongtie Shi, 2017, OncoTargets and therapy.